Evofem Biosciences, Inc. cotiza a 0.01 USD y tiene una capitalización bursátil de $993976. En los últimos 12 meses ha facturado $18M con un margen de flujo de caja libre del -9.9%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. The company's commercial products include PHEXXI, a hormone-free contraceptive vaginal gel; and SOLOSEC, a single-dose oral antimicrobial agent for the tr…
| Periodo | 2024-03 | 2023-01 | 2022-08 | 2022-05 |
|---|---|---|---|---|
| Real | $-0.44 | $20.15 | $-105.75 | $-350.64 |
| Estimado | $-0.61 | $-31.25 | $-120.00 | $-356.25 |
| Sorpresa | +27.9% | +164.5% | +11.9% | +1.6% |
| Métrica | EVFM | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 77.1% | 57.0% | +20.1% |
| Operating Margin | 16.7% | -38.6% | +55.3% |
| Net Margin | 1.9% | -33.6% | +35.5% |
| FCF Margin | -9.9% | -13.9% | +4.0% |
| ROE | — | -40.4% | — |
| ROA | 1.9% | -32.0% | +33.9% |
| Current Ratio | 0.18 | 2.84 | -2.66 |
| Debt / Equity | — | 0.28 | — |